Fertility services are treatments, which aid in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. The global fertility services market was valued at $16,761 million in 2016, and is estimated to reach at $30,964 million by 2023, registering a CAGR of 9.3% from 2017 to 2023.
The global fertility services market is expected to witness a substantial growth in future owing to rising incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in fertility procedures, and increased occurrences of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth.
Recent innovations in IVF technology, such as embryoscope and capsule IVF, are anticipated to augment the demand of fertility devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies, and ethical considerations are projected to hinder the market growth. Increase in upsurge of fertility clinics and same sex marriages are projected to offer lucrative growth opportunities in future. In addition, fertility tourism is expected to provide ample growth opportunities especially in the developing economies.
The global fertility services market comprises four key segments namely, procedures, services, end users, and geography. The procedures market considered in this report include, in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), and others. Based on services, the global fertility services market is categorized into fresh non-donor, frozen non-donor, egg and embryo banking, fresh donor, and frozen donor. The global IVF devices market by end users is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Procedure
IVF with ICSI
Surrogacy
IVF without ICSI
IUI
Others (GIFT and ZIFT)
By Service
Fresh Non-Donor
Frozen Non-Donor
Egg and Embryo Banking
Fresh Donor
Frozen Donor
By End User
Fertility clinics
Hospitals
Surgical centres
Clinical research institutes
Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
The list of key players operating in this market include:
Apollo Hospitals Enterprise Ltd
Care Fertility Group
Carolinas Fertility Institute
Genea Limited
The Johns Hopkins Health System Corp
Medicover Group
Monash IVF Group
OvaScience Inc.
Progyny Inc.
Xytex Cryo International
